Skip to main content
SpringerPlus

Table 1 The tumor markers were significantly reduced during the treatment progress

From: Successful ceritinib treatment in a man with MPE and an ALK fusion gene mutation after multiple treatments

Time

8/1

8/28

9/7

10/17

11/20

12/21

CEA (ng/ml)

61.11

24.66

13.85

7.15

3.3

2.81

CA125 (U/ml)

813.8

242.9

188.1

167

102.9

89.6

Back to article page